Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.

Source:http://linkedlifedata.com/resource/pubmed/id/18413164

Download in:

View as

General Info

PMID
18413164